Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

LB PHARMACEUTICALS INC COM SHS (LBRX)

67 + Investors. Track Smart Money conviction in LBRX. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +14
Streak
2Q ▲
Buyers last Q
60%

Smart Money Signals — LBRX

Based on 67 hedge funds · latest filing: 2025 Q4 · updated quarterly

📈

Buying streak — 2 quarters in a row

last 6Q
For 2 consecutive quarters, more hedge funds added LBRX than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (100% of max)

100% of all-time peak
67 hedge funds hold LBRX right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
🚀

Fast accumulation — +6600% more funds vs a year ago

fund count last 6Q
+66 new funds entered over the past year (+6600% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.
🟢

More buyers than sellers — 60% buying

45 buying30 selling
Last quarter: 45 funds were net buyers (32 opened a brand new position + 13 added to an existing one). Only 30 were sellers (12 trimmed + 18 sold completely). A clear majority buying is a strong confirmation signal.
⚠️

Fewer new buyers each quarter (-20 vs last Q)

new funds entering per quarter
Funds opening this position for the first time: 0 → 0 → 52 → 32. Each quarter fewer new institutions are entering. This usually means most funds that wanted in are already in — the stock is well-known but the pool of potential new buyers is shrinking.
🔄

Mostly new holders — 93% entered in last year

■ 6% conviction (2yr+) ■ 1% medium ■ 93% new
Only 4 funds (6%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.
💰

Value +78% but shares only +24% — price-driven

Value
+77%
Shares
+24%
Last quarter: the total dollar value of institutional holdings rose +78%, but actual share count only changed +24%. The gap is explained by the stock's price rising — not new buying. Strong value growth with weak share growth means the rally is price momentum, not fresh institutional demand.
➡️

Steady discovery — ~32 new funds/quarter

0 → 0 → 0 → 52 → 32 new funds/Q
New funds entering each quarter: 0 → 0 → 52 → 32. Consistent flow of new institutional buyers without clear acceleration or slowdown.
🌱

Early stage — 93% of holders entered in last year

■ 7% veterans ■ 0% 1-2yr ■ 93% new
Of 67 current holders: 62 (93%) entered in the past year, only 5 (7%) are 2+ year veterans. This is an early-phase institutional idea — still being discovered. High upside potential if the thesis plays out, but thin conviction base.
✅

Strong quality — 24% AUM from major funds

24% from top-100 AUM funds
27 of 67 holders rank in the top 100 by AUM, accounting for 24% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.
7.3
out of 10
High Exit Risk
Exit risk score 7.3/10 — multiple crowding signals converge. Institutional ownership is at 100% of its all-time high — near peak crowding. Crowded trades can unwind fast — a single catalyst can trigger a cascade.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — LBRX

In 2025 Q4, 45 hedge funds were net buyers of LBRX (32 opened a new position, 13 added to an existing one), while 30 reduced or exited (12 trimmed, 18 sold completely) — a 60% buyer ratio, indicating clear institutional accumulation. Net buying has persisted for two consecutive quarters, a positive momentum signal. 24% of total institutional value in LBRX is held by top-100 AUM funds, reflecting strong institutional quality. Net fund flow last quarter: +14 funds (more new holders than closures). Total institutional holders: 67.

Hedge Fund Ownership: LBRX

How many hedge funds hold LBRX — quarterly history vs. share price
Quarterly hedge fund ownership of LBRX vs. share price

Market Analysis: LBRX

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: LBRX

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Loading signal freshness…
Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

20 top-rated funds 2 high-conviction
Consensus
5.7
/ 10
breadth
×
Elite
2.3
/ 10
conviction
Hedge Fund Positioning: LBRX
2026 Q1 Stats Unlock in 1 days 67 + Investors

Track Smart Money conviction in LBRX. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2025 Q4) Prior (2025 Q3) Change
Funds Holding 67 53 26.42%
13F Shares 25M 20M 24.28%
Total Value $552M $310M 77.65%
New Positions 32 53 -21
Increased Positions 13 0 +13
Closed Positions 18 0 +18
Reduced Positions 12 0 +12
Total Calls 0 0 -
Total Puts 0 0 -
PUT/CALL Ratio 0.0 0.0 Bullish

Statistics: LBRX

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

67 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in LBRX. Verified SEC 13F-HR filings.

QUARTER:
Top 25 institutional holders of LBRX — 2025 Q4 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Nan Fung Group Holdings Ltd 12.82% 630,657 $15.6M
2 Spruce Street Capital LP 8.09% 1,376,159 $33.6M
3 Trails Edge Capital Partners, LP 7.45% 1,319,362 $32.5M
4 Caligan Partners LP 2.30% 1,438,070 $34.6M
5 Commodore Capital LP 2.14% 1,500,000 $37.0M
6 GREAT POINT PARTNERS LLC 1.70% 300,000 $7.4M
7 Vivo Capital, LLC 1.65% 800,000 $19.7M
8 Deep Track Capital, LP 1.35% 3,352,804 $82.7M
9 TCG Crossover Management, LLC 1.30% 1,839,489 $45.3M
10 HighVista Strategies LLC 1.18% 173,595 $4.3M
11 Logos Global Management LP 1.13% 915,000 $22.6M
12 Nantahala Capital Management, LLC 0.96% 1,052,894 $26.0M
13 RA CAPITAL MANAGEMENT, L.P. 0.58% 2,208,604 $54.5M
14 ACUTA CAPITAL PARTNERS, LLC 0.50% 28,919 $713K
15 STEMPOINT CAPITAL LP 0.24% 50,000 $1.2M
16 Boxer Capital Management, LLC 0.23% 70,000 $1.7M
17 Integral Health Asset Management, LLC 0.18% 150,000 $3.7M
18 Eversept Partners, LP 0.13% 100,198 $2.5M
19 Alyeska Investment Group, L.P. 0.06% 863,947 $21.3M
20 Opaleye Management Inc. 0.05% 14,506 $358K
21 BALYASNY ASSET MANAGEMENT L.P. 0.03% 923,694 $22.8M
22 BAKER BROS. ADVISORS LP 0.03% 200,000 $4.9M
23 MEYER HANDELMAN CO 0.01% 15,094 $372K
24 Soleus Capital Management, L.P. 0.01% 10,000 $247K
25 JENNISON ASSOCIATES LLC 0.01% 538,216 $13.3M
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — LB PHARMACEUTICALS INC COM SHS (LBRX)

What does the Smart Money Trend signal show for LBRX?

Buying streak — 2 quarters in a row: For 2 consecutive quarters, more hedge funds added LBRX than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for LBRX?

More buyers than sellers — 60% buying: Last quarter: 45 funds were net buyers (32 opened a brand new position + 13 added to an existing one). Only 30 were sellers (12 trimmed + 18 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for LBRX holders?

Strong quality — 24% AUM from major funds: 27 of 67 holders rank in the top 100 by AUM, accounting for 24% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held LBRX?

Mostly new holders — 93% entered in last year: Only 4 funds (6%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.